Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone - Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
iShares Global Healthcare ETF(IXJ)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for IXJ
11/13/2026: IXJ (3-star) is a STRONG-BUY. BUY for 11 days. Simulated Profits (1.85%). Updated daily EoD!
IXJ offers investors broad, global exposure to the healthcare sector by tracking the S&P Global 1200 Health Care Sector Index. Its primary strengths are its extensive diversification across developed markets, strong liquidity, and management by the reputable BlackRock/iShares team. It serves as a defensive core or thematic satellite in a long-term portfolio. Investors should monitor risks such as global drug pricing regulation, patent expiration, and sector-specific policy shifts. It is best suited for long-term investors looking for steady, research-backed growth and dividend income.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While healthcare offers steady innovation-led growth, it may lack the aggressive growth rates found in technology or small-cap sectors. |
| Momentum investor | Strong fit while signal remains positive | The sector often experiences significant momentum during defensive rotations or breakthroughs in medical science. |
| Value investor | Strong fit | Many large-cap pharmaceutical holdings in the fund trade at attractive valuations with reliable cash flows. |
| Dividend/Income investor | Strong fit | Many mature healthcare companies provide consistent dividends, making this a reliable income-oriented play. |
| Low-risk investor | Medium | Healthcare is generally considered a defensive sector, though individual biotech volatility can impact overall fund risk. |
Investor Profile
Ideal Investor Profile
Long-term investors seeking defensive exposure to the healthcare sector with a global footprint.
Suitability
Best suited for passive index followers who want to capture long-term sector growth while diversifying across global markets.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | Medium | Broad sector exposure helps dampen the high volatility typically associated with individual biotech stocks. |
| Market risk | Medium | The fund is subject to general equity market fluctuations, though healthcare is often less cyclical than other industries. |
| Concentration | Medium / high | The portfolio is concentrated in a single sector, meaning it will underperform if healthcare faces adverse regulation. |
| Tracking/expense | Low | BlackRock's efficient management ensures the expense ratio and tracking error remain manageable. |
| Liquidity | Low | High trading volume ensures that liquidity risk is minimal for the average investor. |
| Business/sector quality | Low | The sector comprises high-quality companies with strong balance sheets and essential service offerings. |
Sector & Industry Intelligence
This fund is not assigned to one sector.
Risk Analysis
Volatility
IXJ exhibits moderate volatility, consistent with the defensive but innovation-heavy healthcare sector.
Market Risk
The fund is inherently exposed to equity market risk, specifically focusing on healthcare regulatory environments and clinical success rates.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Sector | Global Pharmaceuticals | 45 | Provides stable exposure to established drug manufacturers and global healthcare leaders. |
| Sector | Biotechnology | 20 | Offers growth potential through innovative drug development and research. |
| Sector | Healthcare Equipment & Supplies | 20 | Targets manufacturers of medical devices and diagnostic tools essential to modern healthcare. |
| Sector | Healthcare Services | 15 | Includes providers and insurers that support the operational infrastructure of the healthcare system. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Very Smooth
The stock has followed a highly orderly price path with minimal short-term disruption.
Analysis of Past Performance
Type ETF | Historic Profit 38.92% | Avg. Invested days 73 | Today’s Advisory Strong Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  5.0 | ETF Returns Performance  5.0 |
| Profits based on simulation | Last Close 11/13/2026 |
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.